Fundz

QOL Medical acquires Evoke Pharma in merger

PRIVATEDec 17, 2025

Acquiring Company

QOL Medical

Acquired Company

Evoke Pharma

Vero BeachSolana BeachBiotechnologyHealth CareBiotechnologyHealth CarePharmaceutical

Description

QOL Medical announced the successful completion of its acquisition of Evoke Pharma, with the transaction concluding on December 15, 2025. Evoke shareholders received $11.00 per share in cash as part of the deal, and Evoke now operates as a wholly owned subsidiary of QOL Medical. The shares of Evoke will be delisted from Nasdaq following the merger.

Quick answer

QOL Medical is acquiring Evoke Pharma, announced December 17, 2025. QOL Medical is based in Vero Beach, Florida, United States.

How much did QOL Medical pay for Evoke Pharma?
The deal value was not disclosed.
What does QOL Medical do?
QOL Medical is a specialty biopharmaceutical company committed to delivering solutions for rare diseases.
Where are QOL Medical and Evoke Pharma based?
QOL Medical is based in Vero Beach, Florida, United States. Evoke Pharma is based in Solana Beach, California, United States.
Who are the decision-makers at QOL Medical?
Fundz holds 2 contacts at QOL Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Pharmaceutical and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at QOL Medical, and when

When QOL Medical changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day QOL Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QOL Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QOL Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QOL Medical

Location

Vero Beach, Florida, United States

About

QOL Medical is a specialty biopharmaceutical company committed to delivering solutions for rare diseases. Founded in 2003, QOL Medical focuses on improving clinical outcomes and enhancing the quality of life for patients with rare diseases through the acquisition and commercialization of orphan and gastrointestinal products in underserved markets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QOL Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Paul
Likely contact at this company
••••••••@••••••••

See Paul's verified email →

Anthony
Likely contact at this company
••••••••@••••••••

See Anthony's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for QOL Medical's next move

Learn about Strategic plan

Frequently asked

Who acquired Evoke Pharma?

Evoke Pharma was acquired by QOL Medical, based in Vero Beach. The deal was reported on December 17, 2025. QOL Medical is a specialty biopharmaceutical company committed to delivering solutions for rare diseases. QOL Medical is privately held and operates in Biotechnology.

When did QOL Medical acquire Evoke Pharma?

QOL Medical's acquisition of Evoke Pharma was reported on December 17, 2025. QOL Medical announced the successful completion of its acquisition of Evoke Pharma, with the transaction concluding on December 15, 2025. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Evoke Pharma do?

Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray. It is privately held, operating in Biotechnology, and is based in Solana Beach.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.